First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...